JamesLHollyMD.com

	James L. Holly, M.D.

About SETMA Joint Commission Contact Information History Mission Statement Medical Home Scope of Services I-CARE Initiative Infusion Center The SETMA Way - What is it? SETMA's Model of Care Patient-Centered Medical Home The SETMA Approach to Patient Care	In The News Letters Vital Signs - Examiner Publication SETMA's Providers as of January, 2015 SETMA Knows - Abraham Lincoln and Healthcare Analytics SETMA – 1999 – Four Seminal Events PC-PCC Award January, 2015 Vital Signs Spring 2015 Vital Signs Q&A for PC-PCC Award Links to SETMA 2012 eHealth Innovator Award for LESS initiative Handout for Attendees eHealth Conference January 12, 2012 eHealth Initiative 2012 Award Program Application The eHealth Initiative's 2012 Award Letter 2012 National Quality Forum National Healthcare Improvement Award Effective prioritization of performance improvement goals Dashboard to Measure and Manage Whole System Performance Commitment to transparency Date-driven improvement of NQS priorities Demonstration of readiness to assume responsibilities of an ACO Demonstrated results on publicly reported performance measures Public Reporting Quality Metrics for 2009, 2010, 2011 Internally Tracked Reporting Quality Metrics for 2009, 2010, 2011 Complete Application in PDF Format SETMA's Medical Home Pilgrimage 2009 Medical Home Series I 2010 Medical Home Series II 2011 Medical Home Series Two 2009, 2010, 2011 Medical Home Miscellaneous Articles The Dr. and Mrs. James L. Holly Distinguished Professorship Universal American Letter of Transmittal for Support Dr. Holly's Acceptance Address for the 2012 Distinguished Alumnus Award CMS Medical Home Feedback Report Qualify & Cost SETMA questions Influenza Data SETMA I - October 2011 SETMA II - October 2011 Mark A. Wilson Clinic SETMA West - October 2011 SETMA and Fox 4 News - Healthy Living Videos SETMA Advertisements - Display and Video SETMA Announcements Featured Content Archive	Syllabus PC-MH Externship SETMA's MS4 Patient-Center Medical Home Selective Syllabus Introduction to SETMA's Senior Externship and Syllabus An Introduction to the Origins and Beginnings of Southeast Texas Medical Associates, LLP Patient-Centered Communication PC-MH Health Affairs August 15, 2013 Policy Brief -- Health Gap SETMA 8.20.13 Provider Training -- Health Affairs 2.14.13 -- Patient Engagement SETMA Provider Training 8.20.13 during First Senior Medical Student PC-MH Externship Medical Home Coordination Review Tutorial 2011 Medical Home Series Two Teaching Tool for PC-MH Course - Patient Care Activation, Engagement, Shared-Decision Making	Patient Information What Does Patient-Centered Medical Home Mean to You? What Does Patient-Centered Medical Home Mean to You? Health information exchange Patient Rights and Responsibilities Patient Directions Contact SETMA – Secure Texting What is HIPAA? Authorization To Release or Obtain Medical Records Complete Privacy Policy Website Privacy Policy	Presentations Invited Presentations SETMA Provider Training
Governance Board Governance Board Responsibilities Governance Board Leadership Training The SETMA Team and The SETMA Culture SETMA's Mission, Vision and Goals: Patient Safety and Quality Care Harassment, Neglect, Abuse, Exploitation - Role of HCAHPS & CAHPS Healthcare Provider Standards Providers Responsibility Medication Refills, Reconciliation and Maintenance Provider and Leadership Use of Data and Analytics Commitment To All Patients -- Ethnic Disparities Kaizen - Board Creates Culture of Safety and Quality SETMA's Policy and Practice for Advanced Directives SETMA's Policy on Completion of Medical Records Care Guidelines : Improve processes to evaluate and treat Integrated patient safety program (Sentinel Events) Effectively Manages all programs, services or sites Provides Patients with information about Primary-care Medical Home Organization-wide Planning to Maintain Focus on safety and quality Organization-wide Planning to Maintain Focus on safety and quality SETMA's Performance Quality & Safety Judged by CMS SETMA's Performance Quality & Safety Judged by CMS SETMA Awarded by HIMSS for Quality and Safety 2011 John M. Eisenberg Patient Safety and Quality Awards Application Healthcare Quality Award 2012 Principles of Quality and Metrics Principles Contacting SETMA & Secure Texting PC-MH Mission, Vision, Goal, Access, End-of-Life Communications and Public Reporting Change Existing Processes to Improve Performance Team Members Focused on Safety and Quality	Your Life Your Health View Articles by Subject Aging Well Behavioral Health Cardiovascular Disease Risk Care Coordination Care Transitions Children's Health COGNOS Project Diabetes Exercise Healthcare Reform:Public Policy HIPAA & Security Labor Day Less Initiative Medical Home Medical Records Men's Health Mental Health Nutraceuticals Nutrition Smoking Cessation Thanksgiving Weight Management Women's Health All Articles	Public Reporting Public Reports by Year (2009-2017) Public Reports by Type Fall Risk, Pain, Functional, Wellness, Stress Assessment Fall Risk, Pain, Functional, Wellness, Stress Assessment for 2011 AND 2012 Core Measures: SETMA & Baptist Hospital Core Measures for January to December 2011 PQRS Diabetes Measures - Blood Pressure Diabetes Measures - Glyco and LDL Diabetes Measures - Nephropathy Screening, Foot Exam, and Eye Exam Preventive Measures - Screening (BMI, Colorectal Cancer, Mammography, Osteoporosis) Preventive Measures - Influenza, Pneumococcal, Urinary Incontinence Preventive Measures - Tobacco Use NQF Care for Older Adults Comprehensive CHF Care Diabetes Measures Diabetes Measures - Blood Pressure Control Diabetes Measures - Glyco and LDL Diabetes Measures - Smoking Cessation Female Measures General Health Measures Medication Measures Persistent Medications Medication Measures Pediatric Measures HEDIS (NCQA) Effectiveness of Acute Care Effectiveness of Chronic Care - Clinic/Hospital Effectiveness of Chronic Care - Clinic Only Effectiveness of Chronic Care - Diabetes (Smoking Cessation) Effectiveness of Chronic Care - Diabetes (Glyco and LDL) Effectiveness of Chronic Care - Diabetes (Blood Pressure Control) Effectiveness of Preventive Care Effectiveness of Preventive Care - Older Adults Effectiveness of Chronic Care - Diabetes Measures Effectiveness of Chronic Care - Persistent Medications (MPM) NCQA Diabetes Recognition Program Audit LESS Initiative PCPI PCPI Hypertension PCPI Diabetes PCPI Chronic Stable Angina PCPI Care Transitions PCPI CHF PCPI Weight Management PCPI CKD Stages IV V SETMA Lipid Audit Lipids Treatment Audit Tutorial Lipids Tutorial AQA COGNOS Project SETMA Audit for CKD Stages I III Patient Satisfaction Survey	Accreditations/Awards Achievements which have Advanced SETMA: The Time-line, Philosophy and Principles which Underlie that Advancement Awards	Diabetes Center of Excellence Education Diabetes Order Referral Form Seven Stations 2011 Advances in Diabetes Diabetes Tutorial Diabetes Prevention
EPM Tools Association of Medication and Diagnosis Automated Team Function Behavioral Health Adult Weight Management Tutorial Annual Questionnaires: Fall, Functional, Pain, Stress, Wellness Behavioral Health in SETMA's Patient-Centered Medical Home Model of Care Depression Tutorial Fall Risk Tutorial Health Insurance Portability and Accountability Act (HIPAA) Privacy Tutorial Intensive Behavioral Therapy (IBT) Obesity and Cardiovascular Disease Medicare Preventive LESS Initiative Tutorial Medical Home Transtheoretical Model Assessment Stages of Change Tutorial Pain Management Tutorial Reduction of Antipsychotic Medications Toolkit Smoking Cessation Tutorial Stratifying End-of-Life Risk for Hospice Services Tutorial Chronic Conditions Tutorial Chronic Renal Disease Management Tool Tutorial Calculating the Stages of Renal Disease Proteinuria Disease Management Tools Acute Coronary Syndrome Tutorial Adult Weight Management Tutorial Angina Tutorial Cardiometabolic Risk Syndrome Tutorial Chronic Renal Disease Tutorial Congestive Heart Failure Tutorial Diabetes Tutorial Hypertension Tutorial Lipids Tutorial Lipid Quality Audit Tutorial Primary Pulmonary Hypertension Tutorial Framingham Cardiovascular Risk Cardiometabolic Risk Assessment Framingham Heart Study Risk Calculators Tutorial Frederickson Classification of Dyslipidemia LDL Level Lipid Disease Management Risk Assessment General principles about ICD-9 Codes and HCC/RxHCC Codes Charge Posting Tutorial Coding to Ensure Accurate Health Risk Scoring E & M Codes Tutorial HCC & RxHCC Risk HCC/RxHCC Risk Tutorial ICD-9 Code Training Manual Hepatitis Screening Hospital Based Tools Hospital Care Summary and Post Hospital Plan of Care and Treatment Plan Tutorial Admission Orders Tutorial Daily Progress Notes Tutorial Care Transition Data Set from PCPI Tutorial Using The Clinic and Hospital Follow-up Call Templates Respiratory Failure Tutorial Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS): Tutorial for SETMA's Internal HCAHPS Survey Master GP Suite of Templates Master GP Suite of Templates Tutorial Medical Home Support Materials Department of Care Coordination, Director of Care Coordination and Care Coordination Referral Template Electronic Tickler File Electronic Tickler File Tutorial Follow-up Calls Intensive Behavioral Therapy (IBT) Obesity and Cardiovascular Disease Medicare Preventive Services Medical Home Coordination Review Tutorial Medical Home Plan of Care and Treatment Plan Medical Home Transtheoretical Model Assessment Stages of Change Tutorial Patient-Centered Medical Home Annual Questionnaires Patient-Centered Medical Home: SETMA's Medical Home Coordination Review (MHCR) Tutorial Patient Document for Coordination of Care Transitions of Care Management Coding (TCM Code) Tutorial Merit-Based Incentive Payment System (MIPS) Quality Metric Tool Tutorial Nursing Home Depression Tutorial Fall Risk Tutorial Hydration Assessment Tutorial Nursing Home Guidelines for Care Tutorial Nursing Home Principal Suite of Templates Nutrition Assessment Tutorial Reduction of Antipsychotic Medications Toolkit Skin Care Tutorial Outpatient Infusion Center for Intravenous Antibiotic Therapy and Other Meds Preventive Health Tools Adult Weight Management Tutorial CHF Exercise Tutorial Diabetic Exercise Tutorial Diabetes Prevention Tutorial Exercise Prescription Tutorial Hypertension Prevention Tutorial Intensive Behavioral Therapy (IBT) Obesity and Cardiovascular Disease Medicare Preventive Initial Preventive Physical Exam & Annual Wellness Visit Tutorial LESS Initiative Tutorial Progression to Type 2 Diabetes Smoking Cessation Tutorial Progression to Type 2 Diabetes Quality Metrics ACO and Medicare Advantage Stars HEDIS: NCQA, History, Quality, Safety, STARS, ACO ACO Quality Measures Performance Tool ACO Quality Measures Performance Tool Tutorial STARs - A Tutorial for Utilizing SETMA's Deployment of the STARS MA Program Specialized Tools Annual Questionnaires: Fall, Functional, Pain, Stress, Wellness Association of Medication & Diagnosis Chronic Conditions Tutorial Chronic Care Management Code (CCM) Tutorial Depression Tutorial Drug Interactions Tutorial Electronic Tickler File Tutorial Evaluation Lower Urinary Tract Symptoms in the Male Fall Risk Tutorial Future Labs Tutorial Hydration Assessment Tutorial HCC Risk Training Tool Hypertension: Fulfilling Quality Metrics for the PCPI Program Laboratory Results - Signing Off: Why and How Medication Module Tutorial Medication Reconciliation Tutorial Nutrition Tutorial Pain Management Tutorial Problem List Reconciliation Tutorial Progression to Type 2 Diabetes Referral Skin Care Tutorial SOAAP Opioid Risk Assessment Stratifying End-of-Life Risk for Hospice Services Tutorial Texas State Reportable Infectious Diseases Tutorial Transitions of Care Management Coding (TCM Code) Tutorial	Transforming Your Practice Library Introduction to SETMA's TCPI Library Transforming Your Practice (TCPI) Summary Document of TCPI CMS Quality 12.2015 TCPI Leadership and Governance Care Coordination HIPPA and Security Data Analytics Care Transitions LESS Initiative Medical Records Clinical Decision Support Hospital Care Tools Disease Management Tools Preventive Health Tools Behavioral Health Transformation Tools New Transformation Tools Patient-Centric Care Nursing Home Medical Home Display and Explanation of SETMA's Patient-Centered Medical Home Tools	Medical Home The Story and the Ideals Introduction to Preventive Health Tools PC-MH Patient Engagement & Alternative Payment Models Preventive Care: The Best Way to Treat Illness is Don’t Get it Coordination of Care Patient-Centric Care Population Health Transition of Care - One form of Care Coordination HCAHPS - Hospital Consumer Assessment Of Healthcare Providers and Systems CAHPS - Consumer Assessment of Health Care Provider and Systems Teaching Tool for PC-MH Course – Patient Care Activation, Engagement, Shared-Decision Making Display & Explanation of PC-MH Tools SETMA's Medical Home Pilgrimage Concierge Medicine not Medical Home Medical Neighborhood Security & HIPPA Referrals Patient Web Portal Health Information Exchange Medication Reconciliation The Automated Team Coordination of Care Medical Home Description & Standards AAAHC Joint Commission NCQA Planetree URAC NCQA Interview February 14, 2014	Facebook	Letters

Your Life Your Health - Quantifying Global Cardiovascular Risk: American Heart Association Statement

James L. Holly,M.D.

July 26, 2007

Your Life Your Health - The Examiner

Once you know the cardiovascular risk factors, you will want to know what your personal risk is for short term and long term cardiovascular disease. The most useful risk score is called the Framingham Cardiovascular and Cerebrovascular Risk Score. SETMA automatically calculates this score on all of our patients. Where did this risk score come from?

For 50 years, the Framingham Heart Study and the residents of Framingham, Massachusetts, have been synonymous with the remarkable advances made in the prevention of heart disease in the United States and throughout the world. Data collected from residents of Framingham have produced over 1,000 scientific papers, identified major risk factors associated with heart disease, stroke and other diseases, paved the way for researchers to undertake singular clinical trials based on Framingham findings, created a revolution in preventive medicine, and forever changed the way the medical community and general public view the genesis of disease.

The study is one of the most important epidemiological studies in the annals of American medicine. While its contributions in the area of heart research are legion, researchers also are utilizing new data to investigate stroke, dementia, osteoporosis, arthritis, diabetes, eye disease, cancer and the genetic patterns of many common diseases.

Two generations of study participants and dedicated researchers from the National Heart, Lung, and Blood Institute (NHLBI), Boston University, other area universities and collaborators around the world have revolutionized the way we view, treat and prevent cardiovascular disease and a host of other disorders. Investigators hope to add a third generation of participants in the near future.

Before Framingham, most physicians believed that atherosclerosis was an inevitable part of the aging process and were taught that blood pressure was supposed to increase with age enabling the heart to pump blood through an elderly person's narrowed arteries. efore Framingham, the notion that scientists could identify and individuals could modify "risk factors" ( a term coined by the study) tied to heart disease, stroke and other diseases was not part of standard medical practice. The majority of physicians did not understand the relationship, for example, between high levels of serum cholesterol and heart attacks. Many did not believe that modifying certain behaviors could enable their patients to avoid or reverse the underlying causes of serious heart and vascular conditions. It is from this study that the Framingham Risk Score was developed.

Framingham Global Risk Assessment Scoring

Risk Factor	Risk Points
	*Male*	*Female*
Age, years
< 34	-1	-9
35-39	0	-4
40-44	1	0
45-49	2	3
50-54	3	6
55-59	4	7
60-64	5	8
65-69	6	8
70-74	7	8
Total cholesterol, mg/dL
< 160	-3	-2
169-199	0	0
200-239	1	1
240-279	2	2
280	3	3
HDL cholesterol, mg/dL
< 35	2	5
35-44	1	2
45-49	0	1
50-59	0	0
60	-2	-3
Systolic blood pressure, mm Hg
< 120	0	-3
120-129	0	0
130-139	1	1
140-159	2	2
> 160	3	3
Diabetes
No	0	0
Yes	2	4
Smoker
No	0	0
Yes	2	2

Adding up the points

*Age*

*Cholesterol*

*HDL-C*

*Blood pressure*

*Diabetes*

*Smoker*

Total points

10-Year Risk by Total Framingham Point Scores

Point Total	10-Year Risk

< 9	< 1%
9	1%
10	1%
11	1%
12	1%
13	2%
14	2%
15	3%
16	4%
17	5%
18	6%
19	8%
20	11%
21	14%
22	17%
23	22%
24	27%
25 or more	30%

Obesity

The AHA American Heart Association defines obesity as a major risk factor for cardiovascular heart disease. That risk is accentuated when obesity has a predominant abdominal component. Obesity typically raises blood pressure and cholesterol levels and lowers HDL-C levels. It predisposes to type 2 diabetes and adversely affects other risk factors: triglycerides; small, dense LDL particles; insulin resistance; and prothrombotic factors.

Although not shown by the Framingham data, other long-term longitudinal studies suggest that obesity predicts CHD independently of known risk factors. The association between excess body weight and CHD seems particularly strong in white Americans. For example, in one long-term prospective study men aged 40 to 65 years with body mass index (BMI) 25 to 29 kg/m2 were 72% more likely to develop fatal or nonfatal CHD than were men who were not overweight. In another study, women whose BMI was 23 to 25 kg/m2 carried a 50% increase in risk for CHD compared with women with lower BMIs.

The overall relation between body weight and CHD morbidity and mortality is less well defined for Hispanics, Pima Indians, and black American women; even so, obesity is a risk factor for type 2 diabetes, which itself is a risk factor for CHD. Much remains to be learned about the biological mechanisms underlying the association between obesity and CHD, but without question, a strong association exists. Consequently, obesity is a strong risk factor for CHD and is a direct target for intervention. Prevention of obesity and weight reduction in overweight persons are integral parts of the strategy for long-term risk reduction.

Physical Inactivity

The AHA also classifies physical inactivity as a major risk factor. Many investigations, including the Framingham Heart Study, demonstrate that physical inactivity confers an increased risk for CHD. The extent to which physical inactivity raises coronary risk independently of the major risk factors is uncertain. Certainly, physical inactivity has an adverse effect on several known risk factors. Even though physical inactivity is an independent risk factor, physical activity levels are difficult to reliably measure in individual patients. For these reasons, physical inactivity is not included in quantitative risk assessment.

In spite of these limitations in assessment, previous studies document that regular physical activity reduces risk for CHD. Physical inactivity constitutes an independent target for intervention. Physicians should encourage all of their patients to engage in an appropriate exercise regimen, and high-risk patients should be referred for professional guidance in exercise training. The AHA recently published practical recommendations for exercise regimens designed to reduce risk for CVD.

Family History of Premature CHD

There is little doubt that a positive family history of premature CHD imparts incremental risk at any level of risk factors. This association has been shown by the Framingham Heart Study. Nonetheless, the degree of independence from other risk factors and the absolute magnitude of incremental risk remain uncertain. For this reason, Framingham investigators did not include family history among the major independent risk factors. The NCEP (National Cholesterol Education Program) counts a positive family history of CHD as an independent risk factor that modifies the intensity of LDL-lowering therapy.

Regardless of whether family history is used to modify risk management in individual patients, the taking of a family history is undoubtedly important. A positive family history for premature CHD calls forth the need to test a patient's relatives for both premature CVD and the presence of risk factors.

Psychosocial Factors

There has long been an interest in the contribution of personality and socioeconomic factors to CHD risk. Recently, specific factors including hostility, depression, and social isolation have been shown to have predictive value. These factors, however, are not included in the Framingham data and cannot be incorporated into the model currently. Nonetheless, they might be taken into account in individual patients when an overall strategy for risk reduction is being developed.

Ethnic Characteristics

The Framingham population represents the world's most intensively studied population for cardiovascular risk factors. This study is of great value in developing population-based risk estimates in this population. Because Framingham residents are largely whites of European origin, it is uncertain whether baseline absolute risk is similar to that in other populations. Available evidence suggests that absolute risk varies among different populations independently of the major risk factors. For example, absolute risk among South Asians (Indians and Pakistanis) living in Western society appears to be about twice that of whites, even when the 2 populations are matched for major risk factors.

This higher baseline risk should be considered when South Asians living in the United States are evaluated. Available comparisons of non-Hispanic white, non-Hispanic black, and Hispanic Americans point to a comparable absolute risk status, but large systematic comparisons are in the early stages. It is also possible that some populations have a lower baseline risk than the whites studied in Framingham. For example, results of the Honolulu Heart Study suggest that Hawaiians of East Asian ancestry have only about two thirds the absolute risk of Framingham subjects.

In the Seven Countries Study, the population of Japan exhibited a much lower risk for CHD for a given set of risk factors than other populations. Differences in absolute risk among different demographic groups suggest the need for adjustments in estimates of absolute risk from Framingham scores depending on racial and ethnic origins. Although absolute risk scores may not be transportable to all populations, relative risk estimates probably are reliable across groups. To date, comparison studies are insufficient to provide quantitative estimates of the adjustments needed for Framingham scores when they are applied to individuals from different demographic backgrounds.

In spite of the limitations of the Framingham data, absolute risk estimates as applied to some populations seem applicable to the large populations of non-Hispanic white, Hispanic, and black Americans in the United States. For other groups, relative risk estimates still seem applicable.

Hypertriglyceridemia

Framingham scoring does not ascribe independence to triglyceride levels in risk assessment. Framingham investigators nonetheless have reported that elevated serum triglycerides are an independent risk factor, as have other reports. Hypertriglyceridemia is correlated with other risk factors; however, its degree of independent predictive power is difficult to assess. Several clinical trials found that drugs that primarily affect triglyceride-rich lipoproteins reduce CHD risk when used with patients with hypertriglyceridemia.

Elevated triglycerides consequently may become a target of therapy independent of LDL lowering. The reduction of serum triglyceride levels will also decrease the concentrations of small LDL particles, another putative risk factor. Of course, weight reduction in overweight patients and adoption of regular exercise by sedentary persons will lower triglyceride levels, which is one way in which these changes in lifestyle reduce CHD risk.

Insulin resistance is another risk correlate for CHD.

Insulin Resistance

The mechanisms of association between insulin resistance are complex and likely multifactorial. Regardless, a large portion of all patients who are candidates for global risk assessment have insulin resistance and its accompanying metabolic risk factors (the metabolic syndrome). The components of this syndrome include the atherogenic lipoprotein phenotype (elevated triglycerides, small LDL particles, and low HDL-C levels), elevated blood pressure, a prothrombotic state, and often, impaired fasting glucose.

The metabolic syndrome (Cardiometabolic Risk Syndrome) is a clinical diagnosis, but the risk accompanying it can be assessed in large part by Framingham scoring. This scoring does not count impaired fasting glucose as an independent risk factor, although Framingham publications would support doing so. Insulin resistance can be assumed to be present in a patient with obesity (BMI >30 kg/m2) or overweight (BMI 25 to 29.9 kg/m2) plus abdominal obesity, especially when accompanied by elevated plasma triglycerides, low HDL-C, or impaired fasting glucose.

Insulin resistance is acquired largely through obesity and physical inactivity, although a genetic component undoubtedly exists. The only therapies presently available for insulin resistance for patients without diabetes are weight reduction and increased physical activity.

Remember, it is your life and your health and you should know your personal Framingham Risk Score.

About SETMA	In The News	Syllabus PC-MH Externship	Patient Information	Presentations
Governance Board	Your Life Your Health	Public Reporting	Accreditations/Awards	Diabetes Center of Excellence
EPM Tools	Transforming Your Practice Library	Medical Home	I-CARE Initiative	NextMD